December 2020

Milestone for Women’s HIV Prevention EMA Adopts Positive Opinion on IPM’s Dapivirine Ring to Reduce HIV Risk

2020/07/29: In a milestone for women’s HIV Prevention, the European Medicines Agency (EMA) adopted a positive opinion on the International Partnership for Microbicides (IPM) Dapivirine Vaginal Ring to reduce HIV risk.DF/Net Research welcomes this EMA action which moves a much-needed, woman-initiated HIV prevention option one step closer to reaching women who urgently need it.The monthly

Milestone for Women’s HIV Prevention EMA Adopts Positive Opinion on IPM’s Dapivirine Ring to Reduce HIV Risk Read More »